Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Surgical Trends in Breast Cancer in Turkey: An Increase in Breast-Conserving Surgery.
Çakmak GK, Emiroğlu S, Sezer A, Canturk NZ, Yeniay L, Kuru B, Karanlık H, Soyder A, Gökgöz Ş, Sakman G, Ucuncu M, Akcay MN, Girgin S, Gurdal SO, Emiroglu M, Ozbas S, Öz AB, Arici C, Toktas O, Demircan O, Çalık A, Polat AK, Maralcan G, Demirer S, Ozmen V. Çakmak GK, et al. Among authors: emiroglu s, emiroglu m. JCO Glob Oncol. 2020 Feb;6:285-292. doi: 10.1200/JGO.19.00275. JCO Glob Oncol. 2020. PMID: 32109157 Free PMC article.
Differential Expression of Novel Immune Checkpoint Receptors on Tumor Infiltrating Lymphocytes in Patients with Locally Advanced Breast Cancer after Neoadjuvant Chemotherapy.
Abbasov A, Aktas Cetin E, Cabioglu N, Mollavelioglu B, Onder S, Emiroglu S, Tükenmez M, Muslumanoglu M, Igci A, Deniz G, Ozmen VO. Abbasov A, et al. Among authors: emiroglu s. Neoplasma. 2021 Sep;68(5):1079-1090. doi: 10.4149/neo_2021_210127N141. Epub 2021 Jun 7. Neoplasma. 2021. PMID: 34097428
Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study.
Cabıoğlu N, Karanlık H, Yıldırım N, Müslümanoğlu M, Çakmak Karadeniz G, Trabulus Can D, Tükenmez M, Ersoy YE, Uras C, Zengel B, Emiroğlu S, Polat AK, Yeniay L, Özkurt E, Kara H, İbiş K, Aydıner A, Özmen V, İğci A. Cabıoğlu N, et al. Among authors: emiroglu s. Eur J Surg Oncol. 2021 Oct;47(10):2506-2514. doi: 10.1016/j.ejso.2021.06.024. Epub 2021 Jun 24. Eur J Surg Oncol. 2021. PMID: 34217580
SPECT/CT Lymphoscintigraphy Guidance Simplifies and Improves Targeted Axillary Dissection of the Clipped Nodes After Neoadjuvant Chemotherapy in Initially Node-Positive Breast Cancer.
Has Simsek D, Emiroglu S, Yilmaz R, Bayram A, Isik EG, Tukenmez M, Kuyumcu S, Dursun M, Muslumanoglu M, Cabioglu N. Has Simsek D, et al. Among authors: emiroglu s. Clin Nucl Med. 2022 Nov 1;47(11):e682-e688. doi: 10.1097/RLU.0000000000004340. Epub 2022 Jul 15. Clin Nucl Med. 2022. PMID: 35835147
Pure Mucinous Breast Carcinoma With a Favorable Tumor Biology and Clinical Outcomes.
Emiroglu S, Tukenmez M, Karakus S, Karanlik H, Onder S, Ozmen V, Cabioglu N, Ozkurt E, Yilmaz R, Muslumanoglu M. Emiroglu S, et al. Eur J Breast Health. 2022 Oct 1;18(4):353-359. doi: 10.4274/ejbh.galenos.2022.2022-8-1. eCollection 2022 Oct. Eur J Breast Health. 2022. PMID: 36248750 Free PMC article.
High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer.
Mollavelioglu B, Cetin Aktas E, Cabioglu N, Abbasov A, Onder S, Emiroglu S, Tükenmez M, Muslumanoglu M, Igci A, Deniz G, Ozmen V. Mollavelioglu B, et al. Among authors: emiroglu s. World J Surg Oncol. 2022 Oct 21;20(1):349. doi: 10.1186/s12957-022-02810-z. World J Surg Oncol. 2022. PMID: 36271406 Free PMC article.
27 results